Skip to content

Clinical study of body composition analysis and the pathogenesis of severe preeclampsia

Clinical study of body composition analysis and the pathogenesis of severe preeclampsia

Status
Active, not recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400083543
Enrollment
Unknown
Registered
2024-04-28
Start date
2024-04-30
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe preeclampsia

Interventions

Severe preeclampsia group and non-severe preeclampsia group:None

Sponsors

Women's Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1.Pregnant women with singleton pregnancy who visited Nanjing Maternal and Child Health Care Hospital for registration; 2.Age =18 years; 3.Informed and voluntary principles were followed before the experiment, and patients signed an informed consent form;

Exclusion criteria

Exclusion criteria: 1. History of smoking and alcohol abuse; 2. This pregnancy was conceived by assisted reproductive technology and had received immune-related treatment during pregnancy

Design outcomes

Primary

MeasureTime frame
Skeletal muscle content;Body fat content;

Secondary

MeasureTime frame
Skeletal muscle mass;BMI;percentage of body fat;basal metabolic rate;visceral fat area;Skeletal muscle index;Fat mass index;Fat-to-Muscle Ratio;

Countries

China

Contacts

Public ContactFengchan Xi

Women's Hospital of Nanjing Medical University

xifengchan@aliyun.com+86 138 1308 8919

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026